GRAIL Announces Collaborations with Amgen, AstraZeneca, and Bristol Myers Squibb to Evaluate Cancer Early Detection Technology for Minimal Residual DiseaseBusiness Wire • 01/11/21
Moderna Hires Amgen Executive As Chief Commercial Officer To Bolster Vaccine MarketingBenzinga • 01/07/21
The Dogs of the Dow Didn't Hunt in 2020, and 2021 Isn't Looking Much BetterThe Motley Fool • 01/07/21
Amgen Licenses AMG 634, An Investigational Treatment For Tuberculosis And Leprosy, To Medicines Development for Global HealthPRNewsWire • 12/22/20
Update On SOURCE Phase 3 Trial For Tezepelumab In Patients With Severe, Oral Corticosteroid-Dependent AsthmaPRNewsWire • 12/22/20
FDA Approves Amgen's RIABNI™ (rituximab-arrx), A Biosimilar To Rituxan® (rituximab)PRNewsWire • 12/17/20